PTPRC and neoplasm: Focusing on the landscape of tumor-infiltrating immune cells, we sorted CD45+ leukocytes from tumor tissues and conducted scRNA-seq using 10X Genomics technology for individual patients (Fig. 1a and Supplementary Fig. S1).